Epistaxis in hospitalized patients with COVID-19 | Zendy

Valeria Dell’Era | Zendy; R Dosdegani | Zendy; Paolo Aluffi Valletti | Zendy; Massimiliano Garzaro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Epistaxis in hospitalized patients with COVID-19

Author(s) -

Valeria Dell’Era,

R Dosdegani,

Paolo Aluffi Valletti,

Massimiliano Garzaro

Publication year - 2020

Publication title -

journal of international medical research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.421

H-Index - 57

eISSN - 1473-2300

pISSN - 0300-0605

DOI - 10.1177/0300060520951040

Subject(s) - medicine , nasal cannula , covid-19 , continuous positive airway pressure , airway , cannula , oxygen therapy , surgery , anesthesia , intensive care medicine , disease , infectious disease (medical specialty) , obstructive sleep apnea

Spontaneous epistaxis in patients with COVID-19 can represent a clinical challenge with respect to both the risk of contamination and the treatment options. We herein present the data of 30 patients with COVID-19 who developed spontaneous epistaxis while hospitalized at Eastern Piedmont Hospital during March and April 2020. All patients received low-molecular-weight heparin during their hospital stay and required supplementary oxygen therapy either by a nasal cannula or continuous positive airway pressure. Both conditions can represent risk factors for developing epistaxis. Prevention of crust formation in patients with rhinitis using a nasal lubricant should be recommended. If any treatment is required, appropriate self-protection is mandatory.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research